• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

OMER:US

12.8500 USD 0.5200 4.22%

As of 16:30:00 ET on 08/22/2014.

Company Profile for Omeros Corp (OMER)

Omeros Corporation is a biopharmaceutical company developing a pipeline of product candidates for use in orthopedics, rheumatology, urology, cardiovascular medicine, general surgery and pain management.

Contact Information

Omeros Corp

1420 Fifth Avenue
Suite 2600
Seattle, WA 98101
United States
Phone: 1-206-676-5000
Fax: 1-206-676-5005

Key Executives for Omeros Corp (OMER)

Gregory A DemopulosChairman/Pres/CEO/Co-FounderMichael A JacobsenVP:Finance/Chief Acctg Officer
George A GaitanarisVP:Science/Chief Scientific OfcrJ Steven WhitakerVP:Clinical/Chief Medical Ofcr
Kenneth M FergusonVP:Dev/Chief Dev OfcrMarcia S KelbonVP:Patent/Secy/General Counsel
Albert S YuVP:Clinical DevelopmentMichael K InouyeVP:Commercial Operations
Catherine A Melfi "Cathy"VP:Regulatory AffairsTimothy M DuffyVP:Business Development

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil